Browsing Tag
BCAL Diagnostics
2 posts
BCAL Diagnostics (ASX: BDX) shares rise after ClearNote deal — is this the turning point investors were waiting for?
BCAL Diagnostics (ASX: BDX) expands with ClearNote Health deal for ovarian and pancreatic cancer tests—can this pivot revive its struggling stock?
September 18, 2025
BCAL Diagnostics set to begin trading on ASX after raising $7.3m in IPO
BCAL Diagnostics is set to list on the Australian Securities Exchange (ASX) after an initial public offering that…
July 21, 2021